Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Krishna Institute of Medical Sciences Ltd (KIMS) Share Price & Fundamentals

Company Overview

Founded Year

1973

Listed Year

2021

Headquarter

Secunderabad, Telangana, India

MD/CEO

Dr. Bhaskar Rao Bollineni

Website

https://www.kimshospitals.com

Company Facts

What we do

Krishna Institute of Medical Sciences Ltd operates a leading multi-specialty hospital network across India, offering advanced tertiary and quaternary healthcare services.

Founded in

1,973

Market share

Among largest corporate hospital groups in India with over 5000 beds and broad specialty coverage; a regional leader in organ transplants and critical care.

Problem solved

Provides affordable, quality healthcare with state-of-the-art technology addressing critical diseases including cardiac, oncology, neurosciences, and transplants.

Top clients or who we serve

Serving B2C patients nationwide, including outpatient and inpatient services with focus on clinical excellence and accessible care.

Key management

Dr. Bhaskar Rao Bollineni (Chairman & MD), a renowned cardiothoracic surgeon; Dr. Abhinay Bollineni (CEO) with medical and operational leadership.

Our journey and innovations

Founded in 1973, evolved from a single hospital to 18 facilities across India, pioneering robotic surgeries and numerous firsts in transplant and critical care.

Where we operate

Mainly Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala with expanding footprint in India.

Top products or what we offer

Comprehensive hospital services across 40+ specialties including cardiac sciences, oncology, neurology, organ transplantation, and emergency care.

Top brands

KIMS Hospitals — flagship brand with NABH accreditation; advanced robotic surgery units; transplant centers recognized nationally.

Raw materials needed

Medical consumables, pharmaceuticals, surgical equipment, and advanced medical devices.

Raw materials supplier

Various accredited medical suppliers and technology providers; strategic partnerships for latest healthcare technology.

Recurring vs cyclical contribution

Predominantly recurring revenue from hospital services, diagnostics, surgeries, and ancillary services providing stable cash flows.

Our industry position

Market leader in tertiary care and organ transplantation; strong regional presence with expanding multi-specialty network.

Financial highlights

FY25 consolidated revenue Rs. 3067 crore, PAT Rs. 415 crore; steady revenue CAGR around 27%, PAT growth approx 23% yearly.

Geographical revenue split

Revenue largely from India operations, predominantly Telangana and Andhra Pradesh, with growing contributions from Maharashtra, Kerala, and Karnataka.

Order book

Not applicable; revenue driven by ongoing hospital services and patient volumes.

Whats driving growth

Expansion of hospital network, introduction of new specialties, advanced technology adoption, strategic acquisitions, and increasing patient base.

Our future plans

Addition of 2000+ beds via greenfield projects and acquisitions; enhance specialty services and expand geographic coverage.

Our green promise

Focus on sustainability initiatives including Green OT certifications and energy efficiency programs.

Our people and values

Workforce of skilled medical and administrative professionals; culture emphasizes patient-centric care, clinical excellence, and ethical standards.

Key challenges ahead

Managing rapid expansion, maintaining quality standards across network, competitive healthcare market, and rising operational costs.

Interesting facts

First hospital in Telangana to deploy 4-arm da Vinci robot; pioneered several transplant firsts including India’s first COVID double lung transplant.

Risks and strategy

Risk mitigation via diversified services, robust governance, risk management committee, and strict internal controls ensuring compliance and operational integrity.

Market Footprint

Top Clients

Top Clients

Serving B2C patients nationwide, including outpatient and inpatient services with focus on clinical excellence and accessible care.

Top Products

Top Products

Comprehensive hospital services across 40+ specialties including cardiac sciences, oncology, neurology, organ transplantation, and emergency care.

Price Movement & Share Holding

Today's High/Low

700.5718.65

52 Week High/Low

575.8858
Past Returns

1 week

4.52%

1 month

-8.07%

3 month

-11.74%

1 year

-2.36%

3 year

86.61%

5 year

206.15%

Share Holding

Promoters

32.66%

FII

15.01%

DII

33.22%

Retail

12.25%

Others

6.86%

Company Overview

Founded Year

1973

Listed Year

2021

Headquarter

Secunderabad, Telangana, India

MD/CEO

Dr. Bhaskar Rao Bollineni (Chairman & MD)

Website

https://www.kimshospitals.com

Price Movement & Share Holding

Today's High/Low

700.5718.65

52 Week High/Low

575.8858

Past Returns

1 week

4.52%

1 month

-8.07%

3 month

-11.74%

1 year

-2.36%

3 year

86.61%

5 year

206.15%

Share Holding

Promoters

32.66%

FII

15.01%

DII

33.22%

Retail

12.25%

Others

6.86%

Company Facts

What we do

Krishna Institute of Medical Sciences Ltd operates a leading multi-specialty hospital network across India, offering advanced tertiary and quaternary healthcare services.

Founded in

1973

Market share

Among largest corporate hospital groups in India with over 5000 beds and broad specialty coverage; a regional leader in organ transplants and critical care.

Problem solved

Provides affordable, quality healthcare with state-of-the-art technology addressing critical diseases including cardiac, oncology, neurosciences, and transplants.

Top clients or who we serve

Serving B2C patients nationwide, including outpatient and inpatient services with focus on clinical excellence and accessible care.

Key management

Dr. Bhaskar Rao Bollineni (Chairman & MD), a renowned cardiothoracic surgeon; Dr. Abhinay Bollineni (CEO) with medical and operational leadership.

Our journey and innovations

Founded in 1973, evolved from a single hospital to 18 facilities across India, pioneering robotic surgeries and numerous firsts in transplant and critical care.

Where we operate

Mainly Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala with expanding footprint in India.

Top products or what we offer

Comprehensive hospital services across 40+ specialties including cardiac sciences, oncology, neurology, organ transplantation, and emergency care.

Top brands

KIMS Hospitals — flagship brand with NABH accreditation; advanced robotic surgery units; transplant centers recognized nationally.

Raw materials needed

Medical consumables, pharmaceuticals, surgical equipment, and advanced medical devices.

Raw materials supplier

Various accredited medical suppliers and technology providers; strategic partnerships for latest healthcare technology.

Recurring vs cyclical contribution

Predominantly recurring revenue from hospital services, diagnostics, surgeries, and ancillary services providing stable cash flows.

Our industry position

Market leader in tertiary care and organ transplantation; strong regional presence with expanding multi-specialty network.

Financial highlights

FY25 consolidated revenue Rs. 3067 crore, PAT Rs. 415 crore; steady revenue CAGR around 27%, PAT growth approx 23% yearly.

Geographical revenue split

Revenue largely from India operations, predominantly Telangana and Andhra Pradesh, with growing contributions from Maharashtra, Kerala, and Karnataka.

Order book

Not applicable; revenue driven by ongoing hospital services and patient volumes.

Whats driving growth

Expansion of hospital network, introduction of new specialties, advanced technology adoption, strategic acquisitions, and increasing patient base.

Our future plans

Addition of 2000+ beds via greenfield projects and acquisitions; enhance specialty services and expand geographic coverage.

Our green promise

Focus on sustainability initiatives including Green OT certifications and energy efficiency programs.

Our people and values

Workforce of skilled medical and administrative professionals; culture emphasizes patient-centric care, clinical excellence, and ethical standards.

Key challenges ahead

Managing rapid expansion, maintaining quality standards across network, competitive healthcare market, and rising operational costs.

Interesting facts

First hospital in Telangana to deploy 4-arm da Vinci robot; pioneered several transplant firsts including India’s first COVID double lung transplant.

Risks and strategy

Risk mitigation via diversified services, robust governance, risk management committee, and strict internal controls ensuring compliance and operational integrity.

Market Footprint

Top Clients

Top Clients

Serving B2C patients nationwide, including outpatient and inpatient services with focus on clinical excellence and accessible care.

Top Products

Top Products

Comprehensive hospital services across 40+ specialties including cardiac sciences, oncology, neurology, organ transplantation, and emergency care.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions